[Evaluation of the efficacy of the intravenous admixture of aspartate magnesium hydrochloride with beta-mimetics in the treatment of impending premature labor].
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage*; D001224:Aspartic Acid / Q000008:administration & dosage*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D015149:Tocolytic Agents / Q000008:administration & dosage*
D000318:Adrenergic beta-Agonists; D004338:Drug Combinations; D015149:Tocolytic Agents; D001224:Aspartic Acid
Estimation de l'utilité de l'adjonction d'aspartate hydrochlorure de magnésium par voie intraveineuse aux bêta-mimétiques dans le traitement de la menace d'accouchement prématuré.